Andrew Mok
Stock Analyst at Barclays
(2.32)
# 2,524
Out of 4,711 analysts
135
Total ratings
41.24%
Success rate
-1.09%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Overweight | $91 → $93 | $59.58 | +56.09% | 6 | Dec 13, 2024 | |
| RDNT RadNet | Maintains: Overweight | $79 → $85 | $72.70 | +16.92% | 5 | Dec 4, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $603 → $655 | $500.13 | +30.97% | 5 | Nov 27, 2024 | |
| ACHC Acadia Healthcare Company | Maintains: Overweight | $76 → $43 | $37.90 | +13.46% | 11 | Nov 22, 2024 | |
| AGL agilon health | Maintains: Underweight | $5 → $2 | $1.97 | +1.52% | 2 | Nov 11, 2024 | |
| THC Tenet Healthcare | Maintains: Overweight | $171 → $190 | $129.46 | +46.76% | 10 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Overweight | $396 → $392 | $303.62 | +29.11% | 8 | Nov 8, 2024 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $19 → $21 | $20.07 | +4.63% | 6 | Nov 8, 2024 | |
| CVS CVS Health | Maintains: Overweight | $75 → $71 | $44.36 | +60.05% | 6 | Nov 7, 2024 | |
| CI The Cigna Group | Maintains: Overweight | $405 → $420 | $276.92 | +51.67% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $250 → $253 | $247.10 | +2.39% | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $150 → $164 | $151.85 | +8.00% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7 → $8 | $10.61 | -24.60% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $109 → $116 | $94.45 | +22.82% | 13 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $256 → $271 | $180.11 | +50.46% | 20 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $372 | $294.73 | +26.22% | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $5 | $3.16 | +58.23% | 4 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $622 → $501 | $365.96 | +36.90% | 5 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $131.40 | -36.83% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $35 | $21.22 | +64.94% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $7.65 | +56.86% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $84.47 | +12.47% | 7 | Aug 2, 2022 |
Centene
Dec 13, 2024
Maintains: Overweight
Price Target: $91 → $93
Current: $59.58
Upside: +56.09%
RadNet
Dec 4, 2024
Maintains: Overweight
Price Target: $79 → $85
Current: $72.70
Upside: +16.92%
UnitedHealth Group
Nov 27, 2024
Maintains: Overweight
Price Target: $603 → $655
Current: $500.13
Upside: +30.97%
Acadia Healthcare Company
Nov 22, 2024
Maintains: Overweight
Price Target: $76 → $43
Current: $37.90
Upside: +13.46%
agilon health
Nov 11, 2024
Maintains: Underweight
Price Target: $5 → $2
Current: $1.97
Upside: +1.52%
Tenet Healthcare
Nov 8, 2024
Maintains: Overweight
Price Target: $171 → $190
Current: $129.46
Upside: +46.76%
HCA Healthcare
Nov 8, 2024
Maintains: Overweight
Price Target: $396 → $392
Current: $303.62
Upside: +29.11%
Privia Health Group
Nov 8, 2024
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $20.07
Upside: +4.63%
CVS Health
Nov 7, 2024
Maintains: Overweight
Price Target: $75 → $71
Current: $44.36
Upside: +60.05%
The Cigna Group
Nov 5, 2024
Maintains: Overweight
Price Target: $405 → $420
Current: $276.92
Upside: +51.67%
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $250 → $253
Current: $247.10
Upside: +2.39%
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $150 → $164
Current: $151.85
Upside: +8.00%
Oct 30, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $10.61
Upside: -24.60%
Oct 29, 2024
Maintains: Overweight
Price Target: $109 → $116
Current: $94.45
Upside: +22.82%
Oct 25, 2024
Maintains: Overweight
Price Target: $256 → $271
Current: $180.11
Upside: +50.46%
Oct 25, 2024
Maintains: Equal-Weight
Price Target: $359 → $372
Current: $294.73
Upside: +26.22%
Oct 24, 2024
Maintains: Equal-Weight
Price Target: $3 → $5
Current: $3.16
Upside: +58.23%
Oct 22, 2024
Maintains: Overweight
Price Target: $622 → $501
Current: $365.96
Upside: +36.90%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $131.40
Upside: -36.83%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $35
Current: $21.22
Upside: +64.94%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $7.65
Upside: +56.86%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $84.47
Upside: +12.47%